Search Results 1531-1540 of 17798 for Substance+dependence

  1. C1 esterase inhibitor recombinant (intravenous route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. (HARBOR) Study To Evaluate Efficacy And Safety Of BLU-263 Versus Placebo In Patients With Indolent Systemic Mastocytosis - Mayo Clinic

    ... drug or food, regardless of sBT levels. Entry Criteria for Patients with ISM in Optional PK Group(s). Patients with a 14-day average TSS of < 28 may be ...

  3. Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension - Mayo Clinic

    Diagnosed with idiopathic, heritable, scleroderma, or drug- or toxin-associated pulmonary arterial hypertension (PAH) according to World Health Organization ...

  4. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

    ... drug. 6. Able to understand and voluntarily sign a written informed consent form, which must be signed prior to the performance of any trial-specified study ...

  5. Clinical trials - Oncology (Medical)

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  6. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    This study is being done to evaluate the safety and effects of Food and Drug Administration (FDA) approved medication, Eluxadoline, on bowel function in study ...

  7. Publications - Joshua Bakhsheshian, M.D., M.H.A. - Mayo Clinic

    Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2. Proc Natl Acad Sci U S A. 2013 Dec 17; 110 (51):20801-6 ...

  8. OPsumit USers Registry - Clinical Trials

    About this study. Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) ...

  9. Expanded Access Program with Tirasemtiv for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Is not participating or planning to participate in a clinical trial involving stem cell therapy for the treatment of ALS or another investigational drug.

  10. Nonalcoholic Fatty Liver Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.